Related Experiment Video
Updated: Dec 26, 2025
Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
Published on: February 21, 2019
In Silico and In Vitro Studies of Natural Compounds as Human CK2 Inhibitors
Samer Haidar1, Franziska Jürgens1, Dagmar Aichele1
1Institute for Pharmaceutical and Medicinal Chemistry, Pharma Campus, Westfälische Wilhelms-Universität Münster, Corrensstr. 48, 48149 Münster, Germany.
Background:
Casein Kinase 2 (CK2) is a ubiquitous cellular serine-threonine kinase with broad spectrum of substrates. This enzyme is widely expressed in eukaryotic cells and is overexpressed in different human cancers. Thus, the inhibition of CK2 can induce the physiological process of apoptosis leading to tumor cell death.
Objectives:
Selecting natural inhibitors toward the target enzyme using database mining.
Methods:
With our continuous effort to discover new compounds with CK2 inhibitory effect, several commercial natural databases were searched using molecular modeling approach and the selected compounds were evaluated in vitro.
Results:
Three compounds were selected as candidates and evaluated in vitro using CK2 holoenzyme, their effect on three cancer cell lines was determined. The selected candidates were weak inhibitors toward the target enzyme, only one compound showed moderate effect on cell viability.
Conclusion:
Several natural databases were screened, compounds were selected and tested in vitro. Despite the unexpected low inhibitory activity of the tested compounds, this study can help in directing the search of potent CK2 inhibitors and better understand the binding requirements of the ATP competitive inhibitors.
Insights
Researchers screened natural compounds for Casein Kinase 2 (CK2) inhibition, a target in cancer therapy. While most candidates showed weak activity, one compound moderately affected cancer cell viability, guiding future inhibitor development.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Casein Kinase 2 (CK2) is a serine-threonine kinase widely expressed in eukaryotic cells.
- CK2 overexpression is linked to various human cancers, making it a therapeutic target.
- Inhibiting CK2 can induce apoptosis, leading to tumor cell death.
Purpose of the Study:
- To identify natural inhibitors of Casein Kinase 2 (CK2) through database mining.
- To evaluate the in vitro efficacy of selected natural compounds against CK2.
Main Methods:
- Utilized molecular modeling to screen commercial natural product databases.
- Selected candidate compounds were evaluated in vitro against CK2 holoenzyme.
- Assessed the effect of compounds on the viability of three cancer cell lines.
Main Results:
- Three natural compounds were selected and tested for CK2 inhibitory activity.
- The evaluated compounds exhibited weak inhibition against the target enzyme.
- One compound demonstrated a moderate effect on cancer cell viability.
Conclusions:
- Database screening identified potential CK2 inhibitors from natural sources.
- The study highlights the need for further research to discover potent CK2 inhibitors.
- Findings contribute to understanding the binding requirements for ATP-competitive CK2 inhibitors.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
12:26Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Related Concept Videos
02:34Inhibition of Cdk Activity
02:15M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...